Walleye Trading
OLMA icon

Walleye Trading’s Olema Pharmaceuticals OLMA Stock Holding History

Walleye Trading’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,300
Closed -$18.2K – 5164
2023
Q4 		$18.2K Buy
1,300
+1,100
+550% +$14.8K ﹤0.01% 4525
2023
Q3 		$2.47K Buy
+200
New +$2.04K ﹤0.01% 4747

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Walleye Trading's OLMA Position: Q1 2024 in Review

Walleye Trading sold out of Olema Pharmaceuticals (OLMA) in Q1 2024, closing a stake of 2,193 shares — an estimated $30.8K sold.

Walleye Trading first reported a position in OLMA in Q4 2021 and held it in 3 quarters. The position peaked at $386K in Q4 2021. 126 funds tracked by Wall St. Rank hold OLMA as of Q1 2024.

  • Walleye Trading reported no remaining Olema Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 2,193 Olema Pharmaceuticals shares in Q1 2024, an estimated $30.8K.
  • Walleye Trading first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Walleye Trading's Olema Pharmaceuticals position peaked at $386K in Q4 2021.
  • 126 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.